Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.685 USD | +0.19% | -10.27% | +163.99% |
04-18 | JonesTrading Starts Rezolute With Buy Rating, $10 Price Target | MT |
03-06 | Rezolute, Inc. Reports Validation of the Potential Use of RZ358 for Treatment of Non-Islet Cell Tumor Hypoglycemia | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+163.99% | 108M | |
+6.01% | 111B | |
+11.67% | 106B | |
-12.42% | 22.24B | |
+0.29% | 21.25B | |
-5.06% | 18.97B | |
-35.21% | 18.52B | |
-11.45% | 16.81B | |
+38.17% | 12.54B | |
-24.96% | 8.09B |
- Stock Market
- Equities
- RZLT Stock
- News Rezolute, Inc.
- Cantor Fitzgerald Starts Rezolute at Overweight With $9 Price Target